Keros Therapeutics, Inc. (KROS)
11.67
-2.10
(-15.25%)
USD |
NASDAQ |
Mar 05, 16:00
11.94
+0.27
(+2.31%)
After-Hours: 20:00
Keros Therapeutics Free Cash Flow : 87.08M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amicus Therapeutics, Inc. | 29.85M |
| MannKind Corp. | 13.69M |
| Sarepta Therapeutics, Inc. | -332.39M |
| Insmed, Inc. | -997.58M |
| Ionis Pharmaceuticals, Inc. | -325.67M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 3.249M |
| Cash from Investing (Quarterly) | -0.132M |
| Cash from Financing (Quarterly) | 0.14M |
| Free Cash Flow Per Share (Quarterly) | 0.0767 |
| Free Cash Flow to Equity (Quarterly) | 3.642M |
| Free Cash Flow to Firm (Quarterly) | 3.117M |
| Free Cash Flow Yield | 18.36% |